Showing results (1-10 of 6,003) with videos related to

Sort By:
Pageof 601
Molecular Cancer Therapeutics|October 10, 2020
Targeting Oncogene mRNA Translation in B-Cell Malignancies with eFT226, a Potent and Selective Inhibitor of eIF4APeggy A Thompson, Boreth Eam, Nathan P Young, et al.
Molecular Cancer Therapeutics|October 22, 2020
Inhibition of Lysosomal Function Mitigates Protective Mitophagy and Augments Ceramide Nanoliposome-Induced Cell Death in Head and Neck Squamous Cell CarcinomaJeremy J P Shaw, Timothy L Boyer, Emily Venner, et al.
Molecular Cancer Therapeutics|March 5, 2020
Identification of ALDH1A3 as a Viable Therapeutic Target in Breast Cancer Metastasis-Initiating CellsDaisuke Yamashita, Mutsuko Minata, Ahmed N Ibrahim, et al.
Molecular Cancer Therapeutics|May 28, 2021
Silylation of Deoxynucleotide Analog Yields an Orally Available Drug with Antileukemia EffectsHiroshi Ureshino, Yuki Kurahashi, Tatsuro Watanabe, et al.
Molecular Cancer Therapeutics|May 28, 2021
Targeting Solid Tumors Using CD3 Bispecific AntibodiesAlison Crawford, Danica Chiu
Molecular Cancer Therapeutics|May 28, 2021
First-in-Human, Phase 1 Dose-Escalation Study of Biparatopic Anti-HER2 Antibody-Drug Conjugate MEDI4276 in Patients with HER2-positive Advanced Breast or Gastric CancerMark D Pegram, Erika P Hamilton, Antoinette R Tan, et al.
Molecular Cancer Therapeutics|January 8, 2020
Targeting Tumor Neoangiogenesis via Targeted Adenoviral Vector to Achieve Effective Cancer Gene Therapy for Disseminated Neoplastic DiseaseMyungeun Lee, Zhi Hong Lu, Jie Li, et al.
Molecular Cancer Therapeutics|December 22, 2022
Eradication of Heterogeneous Tumors by T Cells Targeted with Combination Bispecific Chemically Self-assembled NanoringsJacob Petersburg, Daniel A Vallera, Carston R Wagner
Molecular Cancer Therapeutics|June 23, 2021
Targeting TfR1 with the ch128.1/IgG1 Antibody Inhibits EBV-driven Lymphomagenesis in Immunosuppressed Mice Bearing EBV+ Human Primary B-cellsLaura E Martínez, Tracy R Daniels-Wells, Yu Guo, et al.
Molecular Cancer Therapeutics|June 23, 2021
Effective Killing of Acute Myeloid Leukemia by TIM-3 Targeted Chimeric Antigen Receptor T CellsWen-Hsin Sandy Lee, Zhiyong Ye, Alice M S Cheung, et al.
Pageof 601